Skip to main content

Peer Review reports

From: Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience

Original Submission
5 Mar 2021 Submitted Original manuscript
25 Mar 2021 Reviewed Reviewer Report
19 Apr 2021 Author responded Author comments - Marie D’hooghe
Resubmission - Version 2
19 Apr 2021 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
12 May 2021 Reviewed Reviewer Report
13 May 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
14 May 2021 Editorially accepted
22 Jun 2021 Article published 10.1186/s12883-021-02246-0

You can find further information about peer review here.

Back to article page